Type
Sandwich ELISA, Biotin-labelled antibody
Description
The human IL-18 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human IL-18. The human IL-18 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Applications
Serum, Plasma, Cell culture supernatant
Sample Requirements
50 µl/well
Shipping
On blue ice packs. Upon receipt, store the product at the temperature recommended below.
Storage/Expiration
Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).
Calibration Range
78–5000 pg/ml
Limit of Detection
9.0 pg/ml
Intra-assay (Within-Run)
CV = 6.5%
Inter-assay (Run-to-Run)
CV = 8.1%
Spiking Recovery
105%
Dilution Linearity
93%
Specificity
The interference of circulating factors of the immune systeme was evaluated by spiking these proteins at physiologically relevant concentrations into a human IL-18 positive serum.
There was no crossreactivity detected, namely not with IL-18 precursor protein (pro-IL-18).
Features
- RUO
- calibration range 78-5000 pg/ml
- limit of detection 9 pg/ml
- lyophilized controls
- intra-assay CV = 6.5%
- inter-assay CV = 8.1%
Research topic
Cytokines and chemokines and related molecules
Summary
Interleukin (IL) -18 is a newly discovered cytokine, structurally similar to IL-1, with profound effects on T-cell activation.
Formerly called interferon (IFN) gamma inducing factor (IGIF), IL-18 is a novel cytokine that plays an important role in the T-cell-helper type 1 (Th1) response, primarily by its ability to induce IFN gamma production in T cells and natural killer (NK) cells.
In terms of structure, IL-18 and IL-1 beta share primary amino acid sequences of the so-called „signature sequence“ motif and are similarly folded as all beta pleated sheet molecules. Also similar to IL-1 beta, IL-18 is synthesized as a biologically inactive precursor molecule lacking a signal peptide which requires cleavage into an active, mature molecule by the intracellular cysteine protease called IL-1 beta-converting enzyme (ICE, caspase-1). Therefore inhibitors of ICE activity may limit the biologic activity of IL-18 and may be useful as Th1 immunosuppressive agents.
The activity of the mature IL-18 is closely related to that of IL-1.
IL-18 induces gene expression and synthesis of tumor necrosis factor (TNF), IL-1, Fas Ligand, and several chemokines.
IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background.
The activity of IL-18 is via an IL-18 receptor (IL-18R) complex. This complex is made up of a binding chain termed IL-18R, a member of the IL-1 receptor family previously identified as the IL-1 receptor – related protein (IL-1Rrp), and a signaling chain, also a member of the IL-1R family.
The IL-18R complex recruits the IL-1R – activating kinase (IRAK) and TNF-R – associated factor –6 (TRAF-6) with subsequent activation of NF kappa B.
Thus based on primary structure, three-dimensional structure, receptor family, signal transduction pathways and biological effects, IL-18 appears to be a new member of the IL-1 family.
Similar to IL-1, IL-18 participates in both innate and acquired immunity.
Constitutive IL-18 expression is detected from many different cells, including macrophages, keratinocytes, and osteoblasts. Human keratinocytes have been found to be the major producers of IL-18 in unprocessed form.
Instructions for Use (RUO)
Instructions for Use (RUO)
Safety Information (RUO)
MSDS (RUO)
Find documents for the lot